Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients
Sonoda, K.; Meek, A.G.; Strober, S.; Hayashi, R.; Ishimaru, M.; Rapaport, F.T.
Transplantation Proceedings 21(1 Pt 1): 1116-1117
1989
ISSN/ISBN: 0041-1345 PMID: 2650070 Document Number: 329955
Document emailed within 1 workday
Related Documents
Bachetoni, A.; Cinti, P.; Sallusto, F.; Poli, L.; Pretagostini, R.; Alfani, D.; Renna Molajoni, E.; Cortesini, R. 1991: Immunological studies of renal allograft recipients treated with total lymphoid irradiation Allergologia et Immunopathologia 19(2): 69-77Fradelizi, D.; Mahouy, G.; de Riberolles, C.; Lecompte, Y.; Alhomme, P.; Douard, M.C.; Chotin, G.; Martelli, H.; Daburon, F.; Vaiman, M. 1981: Allograft tolerance in pigs after fractionated lymphoid irradiation. II. Kidney graft after conventional total lymphoid irradiation and bone marrow cell grafting Transplantation 31(5): 365-368
Oluwole, S.; Hardy, M.A.; Fawwaz, R.; Todd, G.; Nowygrod, R.; Reemtsma, K. 1979: Selective lymphoid irradiation. II. Comparison with total-body irradiation on cardiac allograft survival in rats Transplantation 28(6): 492-495
Carpenter, C.B.; Milford, E.L.; Kirkman, R.L.; Strom, T.B.; Lazarus, J.M.; Tilney, N.L. 1985: Stability of renal allograft recipients after conversion from cyclosporine to azathioprine Transplantation Proceedings 17(4 Suppl 1: 261-265
Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L. 1991: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression Transplantation Proceedings 23(1 Pt 2): 1104-1105
O'Connell, P.; d'Apice, A.; Walker, R.; Francis, D.; Kincaid-Smith, P. 1988: Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone Transplantation Proceedings 20(1): 11-13
Lan, F.; Hayamizu, K.; Strober, S. 2000: Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after posttransplant total lymphoid irradiation Transplantation 69(4): 649-655
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
MacDonald, A.S.; Daloze, P.; Dandavino, R.; Jindal, S.; Bear, L.; Dossetor, J.B.; Klassen, J.; Stiller, C.R.; Lockwood, B.; Reeve, C.E. 1987: A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group Transplantation Proceedings 19(1 Part 3): 1865-1866
Buturović, J.; Kandus, A.; Malovrh, M.; Bren, A.; Drinovec, J. 1990: Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy Transplantation Proceedings 22(4): 1726-1727
Kahan, B.D.; Kramer, W.G.; Williams, C.; Wideman, C.A. 1986: Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients Transplantation Proceedings 18(6 Suppl 5: 200-203
Kelly, J.J.; Walker, R.G.; d'Apice, A.J.; Kincaid-Smith, P. 1990: A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results Transplantation Proceedings 22(5): 2127-2128
Hayamizu, K.; Zeng, D.; Huie, P.; Garcia-Ojeda, M.E.; Bloch, D.A.; Fong, L.; Engleman, E.G.; Sibley, R.K.; Strober, S. 1998: Donor blood monocytes but not T or B cells facilitate long-term allograft survival after total lymphoid irradiation Transplantation 66(5): 585-593
Faber, R.; Johnson, H.K.; Braren, H.V.; Richie, R.E. 1974: The efficacy of prophylactic irradiation in altering renal allograft survival Proceedings of the Clinical Dialysis and Transplant Forum 4: 135-137
Paul, L.C.; Chea, R.; Davidoff, A.; Benediktsson, H. 1994: Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat Transplantation Proceedings 26(5): 2567-2568
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Vilardell, J.; Oppenheimer, F.; Talbot-Wright, R.; Ricart, M.J.; Andreu, J.; Alcaraz, A.; Carretero, P. 1992: Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine Transplantation Proceedings 24(5): 1948
Watanabe, K.; Yuge, K.; Sato, K.; Yamagishi, K.; Sonoda, K.; Masaki, Y.; Maruyama, S.; Takahara, H.; Matsubayashi, T.; Yago, K. 1989: Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion Transplantation Proceedings 21(1 Part 1): 1112-1115
Durlik, M.; Gaciong, Z.; Soluch, L.; Walecka-Zielecka, B.; Rancewicz, Z.; Rowińska, D.; Rowiński, W.; Szmidt, J.; Lao, M. 1996: Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients Transplantation Proceedings 28(1): 50-51